Industry Strength Score
56/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
AZIYO BIOLOGICS INC-CLASS A (AZYO) Stock Price & Overview
NASDAQ:AZYO • US05479K1060
Current stock price
1.49 USD
+0.03 (+2.05%)
Last:
The current stock price of AZYO is 1.49 USD. Today AZYO is up by 2.05%. In the past month the price decreased by -1.97%. In the past year, price decreased by -79.62%.
AZYO Key Statistics
52-Week Range1.1 - 9.01
Current AZYO stock price positioned within its 52-week range.
1-Month Range1.26 - 1.63
Current AZYO stock price positioned within its 1-month range.
- Market Cap
- 24.212M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -2.25
- Dividend Yield
- N/A
AZYO Stock Performance
Today
+2.05%
1 Week
+4.20%
1 Month
-1.97%
3 Months
-34.36%
Longer-term
6 Months -64.69%
1 Year -79.62%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A
AZYO Stock Chart
AZYO Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to AZYO. When comparing the yearly performance of all stocks, AZYO is a bad performer in the overall market: 95.36% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
AZYO Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to AZYO. AZYO may be in some trouble as it scores bad on both profitability and health.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
AZYO Earnings
Next Earnings DateNov 13, 2023
Last Earnings DateAug 14, 2023
PeriodQ2 / 2023
EPS Reported-$0.65
Revenue Reported
EPS Surprise -119.74%
Revenue Surprise -19.25%
AZYO Forecast & Estimates
7 analysts have analysed AZYO and the average price target is 8.16 USD. This implies a price increase of 447.65% is expected in the next year compared to the current price of 1.49.
For the next year, analysts expect an EPS growth of 9.47% and a revenue growth -12.95% for AZYO
Analysts
Analysts82.86
Price Target8.16 (447.65%)
EPS Next Y9.47%
Revenue Next Year-12.95%
AZYO Financial Highlights
Over the last trailing twelve months AZYO reported a non-GAAP Earnings per Share(EPS) of -2.25. The EPS increased by 22.95% compared to the year before.
Income Statements
Revenue(TTM)48.40M
Net Income(TTM)-33.95M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
Chartmill High Growth Momentum
EPS Q2Q%5.8%
Sales Q2Q%-18.53%
EPS 1Y (TTM)22.95%
Revenue 1Y (TTM)4.13%
AZYO Ownership
Ownership
Inst Owners74.28%
Shares16.25M
Float6.05M
Ins Owners3.94%
Short Float %N/A
Short RatioN/A
AZYO Industry Overview
AZYO operates in the Biotechnology sub-industry within the Health Care sector. This group contains 416 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Growth Score
14/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
66%
Outperformed 66% of sub-industries
3 Month Rank
48%
Outperformed 48% of sub-industries
6 Month Rank
32%
Outperformed 32% of sub-industries
Industry Fundamentals & Breadth
- Members
- 416
- New Highs
- 5.8%
- New Lows
- 3.1%
- Average ROE
- 48.2%
- Average Profit Margin
- 20.9%
- Average Operating Margin
- 33.6%
- Average P/E
- 26.1
- Average Fwd P/E
- 22.4
- Average Debt/Equity
- 2.1
AZYO Competitors/Peers
The largest stocks on the US markets in the "Biotechnology" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 13.79 | 349.666B | ||
| AMGN | AMGEN INC | 14.82 | 183.263B | ||
| GILD | GILEAD SCIENCES INC | 14.55 | 160.44B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 21.76 | 109.41B | ||
| REGN | REGENERON PHARMACEUTICALS | 14.65 | 77.363B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 43.98 | 40.311B | ||
| INSM | INSMED INC | N/A | 29.127B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 28.701B | ||
| NTRA | NATERA INC | N/A | 28.37B | ||
| BIIB | BIOGEN INC | 11.97 | 26.913B | ||
| UTHR | UNITED THERAPEUTICS CORP | 19.52 | 24.944B | ||
| INCY | INCYTE CORP | 10.84 | 19.451B | ||
| MRNA | MODERNA INC | N/A | 18.695B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About AZYO
Company Profile
Aziyo Biologics, Inc. operates as a biotechnology company. The company is headquartered in Silver Spring, Maryland and currently employs 151 full-time employees. The company went IPO on 2020-10-08. The firm has developed a portfolio of regenerative products using both human and porcine tissue that are designed to be as close to natural biological material. The firm operates in four segments: Device Protection, Women's Health, Orthobiologics, and Cardiovascular. Its product portfolio includes CanGaroo, SimpliDerm, ViBone, OsteGro V, Fiber VBM, ProxiCor, Tyke, and VasCure. These products are primarily sold to healthcare providers or commercial partners. In device protection, it sells biological envelopes that form a natural, systemically vascularized pocket for holding implanted electronic devices. In cardiovascular, the Company sells its specialized porcine small intestine submucosa (SIS ECM) for use as an intracardiac and vascular patch. The company also sells human tissue products under contract manufacturing and other arrangements with corporate customers.
Company Info
IPO: 2020-10-08
AZIYO BIOLOGICS INC-CLASS A
12510 Prosperity Drive, Suite 370
Silver Spring MARYLAND 20904 US
CEO: Ronald Lloyd
Employees: 151
Phone: 12402471143.0
AZIYO BIOLOGICS INC-CLASS A / AZYO FAQ
What does AZYO do?
Aziyo Biologics, Inc. operates as a biotechnology company. The company is headquartered in Silver Spring, Maryland and currently employs 151 full-time employees. The company went IPO on 2020-10-08. The firm has developed a portfolio of regenerative products using both human and porcine tissue that are designed to be as close to natural biological material. The firm operates in four segments: Device Protection, Women's Health, Orthobiologics, and Cardiovascular. Its product portfolio includes CanGaroo, SimpliDerm, ViBone, OsteGro V, Fiber VBM, ProxiCor, Tyke, and VasCure. These products are primarily sold to healthcare providers or commercial partners. In device protection, it sells biological envelopes that form a natural, systemically vascularized pocket for holding implanted electronic devices. In cardiovascular, the Company sells its specialized porcine small intestine submucosa (SIS ECM) for use as an intracardiac and vascular patch. The company also sells human tissue products under contract manufacturing and other arrangements with corporate customers.
What is the current price of AZYO stock?
The current stock price of AZYO is 1.49 USD. The price increased by 2.05% in the last trading session.
Does AZYO stock pay dividends?
AZYO does not pay a dividend.
What is the ChartMill rating of AZIYO BIOLOGICS INC-CLASS A stock?
AZYO has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
On which exchange is AZYO stock listed?
AZYO stock is listed on the Nasdaq exchange.
Is AZIYO BIOLOGICS INC-CLASS A (AZYO) expected to grow?
The Revenue of AZIYO BIOLOGICS INC-CLASS A (AZYO) is expected to decline by -12.95% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the market cap for AZIYO BIOLOGICS INC-CLASS A?
AZIYO BIOLOGICS INC-CLASS A (AZYO) has a market capitalization of 24.21M USD. This makes AZYO a Nano Cap stock.